| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.131 | 27.920 | 9.084 | - | 1.062 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 10.131 | 27.921 | 9.084 | - | 1.062 | 1 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 7.254 | 24.302 | 7.203 | - | 8.634 | 485 | 122 | 0 | 0 |
| Gross Profit/Loss - EUR | - | 2.877 | 3.619 | 1.882 | - | -7.572 | -484 | -122 | 0 | 0 |
| Net Profit/Loss - EUR | - | 2.573 | 2.781 | 1.609 | - | -7.604 | -484 | -122 | 0 | 0 |
| Employees | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vendi Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 11.202 | 19.123 | 20.841 | - | 13.368 | 13.029 | 13.068 | 12.122 | 12.054 |
| Inventories | - | 10.143 | 3.616 | 9.521 | - | 6.067 | 5.932 | 5.951 | 5.932 | 5.899 |
| Receivables | - | 0 | 9.004 | 5.388 | - | 6.827 | 6.676 | 6.696 | 5.769 | 5.737 |
| Cash | - | 1.059 | 6.502 | 5.932 | - | 474 | 421 | 421 | 420 | 418 |
| Shareholders Funds | - | 2.592 | 5.330 | 6.841 | - | -4.471 | -4.857 | -4.994 | -4.979 | -4.951 |
| Social Capital | - | 47 | 46 | 45 | - | 43 | 42 | 43 | 42 | 42 |
| Debts | - | 8.610 | 13.793 | 14.000 | - | 17.839 | 17.885 | 18.062 | 17.101 | 17.005 |
| Income in Advance | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4669 - 4669" | |||||||||
| CAEN Financial Year |
4669
|
|||||||||
Comments - Vendi Pharma Srl